Pharmacogenomics Community

The Pharmacogenomics Community combines the disciplines of biochemistry, biophysics, genetics, molecular biology, bioinformatics, and pharmacology to elucidate the mechanisms of drug action, toxicity, metabolism and transport and to identify genetic determinants of variability in drug exposure, response and toxicity.

Community Goals:
  • Facilitate interaction and collaboration between members of the Pharmacogenomics Community via social media and networking opportunities
  • Spur interest and growth in the area of pharmacogenomics
  • Act as the primary home for researchers in the area of pharmacogenomics
  • Support member engagement in the Precision Medicine Initiative

Community Leadership

Kathryn Momary, PharmD, BCPS
Mercer University

Dr. Momary is currently an associate professor at Mercer University College of Pharmacy with appointments in the Departments of Pharmacy Practice and Pharmaceutical Sciences. She currently studies cardiovascular pharmacogenomics.  She has published both original research and review papers in this area and has presented her research at national pharmacy and pharmacology meetings. Full bio

 Vice Chair
Joseph Ware, PhD

Joseph Ware is a Principal Scientist in the Clinical Pharmacology Department at Genentech, Inc.  South San Francisco, CA. 

 During his industrial tenure, Joseph has supported programmatic advancement (from H2L to phase III) in many therapeutic areas (anti-cancer, inflammation, CNS, and anti-infective) and believes that programmatic challenges represent  unique opportunities for clinical pharmacologists to apply emerging technologies and impact drug development decisions and timelines. Full bio.

Join the PG Community >>

Get more involved in the PG Community >> 

Find PG Community Members >> 

528 N Washington St, Alexandria, VA 22314 |  Ph: 703.836.6981 |